Secular trends of antibacterial prescribing in UK paediatric primary care

Verena Schneider-Lindner1, Caroline Quach, James A Hanley

  • 1Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada.

Insights

Antibacterial drug prescribing in UK children declined in the 1990s but has risen significantly since 2000. This trend affects all age groups and antibiotic types, highlighting a need for surveillance.

Area of Science:

  • Pediatric infectious disease
  • Antimicrobial stewardship
  • Public health surveillance

Background:

  • Antibacterial drug resistance necessitates judicious prescribing, particularly in pediatric populations.
  • While UK antibacterial prescribing declined in the 1990s, recent trends require updated surveillance.

Purpose of the Study:

  • To analyze antibiotic prescribing patterns and temporal trends in children aged 0-19 years in the UK over two decades (1993-2007).

Main Methods:

  • Utilized the General Practice Research Database to identify pediatric antibiotic prescriptions from 1993 to 2007.
  • Employed Poisson regression to model prescription rates, accounting for age, gender, calendar year, and practice variations.

Main Results:

  • The study included over 1.75 million children and 5.8 million prescriptions.
  • Prescription rates decreased until 2000, then increased by 40.7% by 2007, with annual increases of 4.3% post-2000.
  • Broad-spectrum penicillins were most common, with their prescription rates rising 4.6% annually after 2000, mirroring trends across most antibacterial classes.

Conclusions:

  • UK pediatric antibacterial prescribing has shown a consistent increase since 2000 across all demographics and drug classes.
  • This sustained rise underscores the importance of ongoing monitoring and antimicrobial stewardship initiatives in pediatric care.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...